Tuesday, October 30, 2012

Treating for Fracture Risk when on Prostate Cancer Hormone Therapy

Treatments to lower testosterone levels are often given to patients with Prostate Cancer.

The lower levels of testosterone can often result in osteoporosis which predisposes patients to fractures.

Patients are often advised to take calcium and vitamin D supplements to minimise the risk of osteoporosis but the actual dosage can be difficult to determine.  Some patients may be taking insufficient amounts of these supplement to make a difference whilst other patients may be taking doses which are so high that they may be causing their own health problems.

This issue is unfortunately made more difficult by a lack of scientific/clinical studies into what dosages  of these supplements are in fact effective.

In the following video, Dr. Gerald Chodak discusses these issues and also talks about a new treatment called Prolia.